Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Tag Archives: Patent pool
A Trade Barrier to Defeating AIDS
By TINA ROSENBERG July 26, 2011 Earlier this month, the patent pool received its first donation of rights from a pharmaceutical manufacturer, Gilead Sciences. It is an important step — but the terms Gilead negotiated are also confirmation of a … Continue reading
The Implications of the Medicines Patent Pool and Gilead Licenses on Access to Treatment
Briefing Paper by ITPC & I-MAK On 12 July, 2011 the Medicines Patent Pool (MPP) and Gilead Sciences, Inc. (Gilead) announced they had entered into a licensing agreement to improve access to anti-retrovirals (ARVs) and Hepatitis B (HBV) treatment in … Continue reading
Posted in Generic drug, HIV/Aids, Medicine Patent Pool
Tagged Antiretroviral drug, Gilead Sciences, Patent pool, Unitaid
Leave a comment
Corporate Self-Interest And Strategic Choices: Gilead Licenses To Medicines Patent Pool
Published on 21 July 2011 @ 8:50 pm Intellectual Property Watch By Prof. Brook K. Baker, Health GAP Summary: Despite some important advances to the scope of its previous purely voluntary licenses on key antiretroviral medicines, Gilead’s licenses with the UNITAID-sponsored … Continue reading
Posted in Drug Pricing, Generic drug, HIV/Aids, Medicine Patent Pool
Tagged Antiretroviral drug, Gilead Sciences, Patent pool, Unitaid
Leave a comment
Open Letter from Thai Civil Society: One Step forward, Two Steps back: the Agreement between the Medicine Patent Pool and Gilead Sciences, Inc
On behalf of the Thai Network of People Living with HIV & AIDS, pharmaceutical academics and civil society organisations working on access to medicines for all in Thailand, we wish to raise our grave concerns regarding the agreement between the … Continue reading
Posted in Generic drug, HIV/Aids, Medicine Patent Pool
Tagged Antiretroviral drug, Generic drug, Gilead Sciences, Patent pool, Thailand
Leave a comment
Medicine Patent Pool’s agreement with Gilead: Is it really a fair deal?
Recently, Medicine Patent Pool signed its first agreement with pharmaceutical company Gilead for the production of the HIV medicines tenofovir, emtricitabine, cobicistat, and elvitegravir as well as a combination of these products in a single pill known as the “Quad.” Click … Continue reading
Posted in Generic drug, HIV/Aids, Medicine Patent Pool
Tagged Aids, Generic drug, Gilead Sciences, HIV, Patent pool, Tenofovir, Unitaid
Leave a comment
